TIMD4 and familial pancreatic carcinoma: Recent research has shown that TIMD4 is up‐regulated in tissues of oesophageal cancer, colorectal cancer, pancreatic cancer, breast cancer and lung cancer, and it can lead to poor prognosis in lung cancer patients by promoting the growth and proliferation of NSCLC cells [33].